Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atheroembolic renal disease causes hypocomplementaemia.

F G Cosio, R A Zager, H M Sharma

    Lancet (London, England)
    |July 20, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Renal Allograft Histology at 10 Years After Transplantation in the Tacrolimus Era: Evidence of Pervasive Chronic Injury.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
    Same author

    Temporal IgG Subtype Changes in Recurrent Idiopathic Membranous Nephropathy.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
    Same author

    Changing Kidney Allograft Histology Early Posttransplant: Prognostic Implications of 1-Year Protocol Biopsies.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
    Same author

    Anti-phospholipase A₂ receptor antibodies in recurrent membranous nephropathy.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
    Same author

    Kidney allograft function and histology in recipients dying with a functioning graft.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
    Same author

    Kidney allograft survival after acute rejection, the value of follow-up biopsies.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    See all related articles

    Atheroembolic renal disease can cause low complement levels (hypocomplementaemia) due to in vivo complement activation. This finding suggests considering atheroembolic disease in patients with multisystem issues and hypocomplementaemia.

    Area of Science:

    • Nephrology
    • Immunology
    • Pathology

    Background:

    • Atheroembolic renal disease is a serious condition affecting the kidneys.
    • Hypocomplementaemia, a state of reduced complement levels, is often associated with autoimmune diseases.

    Purpose of the Study:

    • To investigate the relationship between atheroembolic renal disease and hypocomplementaemia.
    • To explore the mechanism of hypocomplementaemia in atheroembolic renal disease.
    • To assess the diagnostic utility of hypocomplementaemia in atheroembolic renal disease.

    Main Methods:

    • Observation of 7 patients with atheroembolic renal disease.
    • Experimental modeling of atheroembolic disease.
    • Analysis of complement levels, platelet counts, and eosinophil counts.

    Related Experiment Videos

    Main Results:

    • All 7 patients exhibited hypocomplementaemia.
    • Experimental evidence confirmed complement activation by atheromatous material in vivo.
    • 6 patients had thrombocytopenia and 5 had eosinophilia.

    Conclusions:

    • Hypocomplementaemia is a significant finding in atheroembolic renal disease.
    • Atheroembolic disease should be included in the differential diagnosis for hypocomplementaemia.
    • The combination of multisystem disease, hypocomplementaemia, thrombocytopenia, and eosinophilia suggests considering atheroembolic disease.